Showing results 2 to 2 of 2
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens Journal:Breast Cancer Research and Treatment | 2021 |